{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-000462","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2022-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.812174+00:00","generated_at":"2026-06-27T20:57:45.039906+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Silo Pharma sets director compensation: $25k retainer + options, $0.1460 strike, one-year vest","bullets":["Non-employee directors receive $25,000 cash retainer plus 177,233 option shares at $0.1460, one-year cliff vest.","Audit Committee Chair receives additional $12,500 cash fee.","Compensation Committee Chair receives additional $7,500 cash fee.","Option term is 5 years from grant date."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-000462","json":"https://secwatch.observer/filing/0001213900-22-000462.json","markdown":"https://secwatch.observer/filing/0001213900-22-000462.md","text":"https://secwatch.observer/filing/0001213900-22-000462.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022000462/0001213900-22-000462-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022000462/ea153452-8k_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:57:45.039906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}